• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gufic BioSciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 2285.0
  • ISIN : INE742B01025
384.65 -12 (-3.14%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    382.40

  • Today’s High

    400.00

  • Open

    399.40

  • Perv Close

    397.10

  • 52W Low

    298.80

  • 52W High

    504.25

Key Indicators

  • P/E(TTM)

    55.12

  • Mar.Cap (₹Cr.)

    3,857.17

  • Div & Yield %

    0.03

  • Book Value(₹)

    59.97

  • Debt-Equity Ratio

    -3.14

  • AGM Date

    01-Aug-2025

  • EPS

    6.97

  • P/E Ratio

    55.12

Financials Ratios

  • Debt-Equity Ratio

    0.63

  • Mar.Cap (₹Cr.)

    3,857.17

  • RONW (%)

    16.17

  • ROCE (%)

    14.79

Score Board

  • Equity (₹ in Cr.)

    10.03

  • BV (₹)

    60.00

  • Sales( ₹ in Cr.)

    819.81

  • NP (in Cr.)

    69.93

  • NP Var(%)

    -20.0

  • Div%

    10.0

  • CPS (₹)

    9.10

  • EPS (₹)

    7.00

  • Traded Value (₹ in Lakhs)

    3,852.66

  • 52 Week High

    504.25

  • 52 Week Low

    298.80

  • Price BSE

    384.0

  • Price NSE

    385.00

  • Market Capital( in Cr.)

    3,852.66

  • P/C Ratio

    42.30

  • P/E Ratio

    55.10

  • Price Vs.BV

    7.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 806.67 690.62 779.16 487.70 378.84 350.77
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 806.67 690.62 779.16 487.70 378.84 350.77
Other Income 2.18 2.57 3.10 3.73 5.79 4.17
Stock Adjustments -0.57 33.39 19.39 -14.29 10.91 -13.77
Total Income 808.28 726.58 801.65 477.14 395.54 341.17
EXPENDITURE :            
Raw Materials 389.32 365.21 431.35 236.00 190.45 167.00
Power and Fuel Cost 17.79 15.24 11.00 9.94 8.23 3.43
Employee Cost 109.63 86.73 85.61 66.22 58.59 46.85
Other Manufacturing Expenses 28.43 24.67 27.42 18.20 15.93 21.15
Selling and Administration Expenses 104.31 87.99 77.97 45.93 54.08 46.29
Miscellaneous Expenses 10.75 9.51 17.16 13.20 10.35 6.29
Employee Benefit Expenses 109.63 86.73 85.61 66.22 58.59 46.85
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 660.22 589.36 650.51 389.49 337.63 291.01
Operating Profit 148.05 137.22 151.14 87.65 57.90 50.16
Interest 15.36 8.22 5.37 13.63 13.91 10.16
Gross Profit 132.69 129.00 145.77 74.02 43.99 40.00
Depreciation 17.02 22.28 18.93 16.31 13.86 4.65
Profit Before Tax 115.67 106.72 126.84 57.71 30.13 35.35
Current Tax 26.37 28.21 32.15 17.20 8.31 11.53
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.17 -1.19 -1.15 -3.72 -0.87 1.88
Reported Net Profit 86.14 79.70 95.84 44.23 22.69 21.94
Extraordinary Items -1.67 0.02 0.05 0.02 0.01 0.03
Adjusted Net Profit 87.81 79.68 95.79 44.21 22.68 21.91
Adjustment below Net Profit 0.00 0.00 0.00 0.26 0.00 0.39
P & L Balance brought forward 267.29 188.55 93.68 49.58 27.36 44.11
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.97 0.97 0.97 0.39 0.47 0.47
P & L Balance carried down 352.46 267.29 188.55 93.68 49.58 65.98
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 10.00 5.00 5.00
Dividend Per Share(Rs) 0.10 0.10 0.10 0.10 0.05 0.05
Earnings Per Share-Unit Curr 8.59 8.22 9.89 4.56 2.34 2.82
Earnings Per Share(Adj)-Unit Curr 8.59 8.22 9.89 4.56 2.34 2.82
Book Value 53.11 35.88 27.76 17.89 13.34 9.68
Book Value(Adj)-Unit Curr 53.11 35.88 27.76 17.89 13.34 9.68

Shareholding Pattern

  • Promoter Group

    72.51%

  • Public Share Holding

    27.49%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 41,993,298 41.88 41,993,298 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 30,714,853 30.63 30,714,853 2
Sub Total 72,708,151 72.51 72,708,151 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 316,519 0.32 316,519 20
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 3,387,672 3.38 3,387,672 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,704,191 3.69 3,704,191 25
2] Non Institution
Bodies Corporate 4,930,264 4.92 4,930,264 176
Clearing Members 487 0.00 487 2
Directors of their Relatives 566,764 0.57 566,764 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 536,138 0.53 536,138 701
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,709,520 1.70 1,709,520 620
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,003,919 3.00 3,003,919 4
Individuals holding nominal share capital up to Rs. 1 lakh 12,140,362 12.11 12,115,362 30,321
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 261,845 0.26 261,845 2
Sub Total 23,865,164 23.80 23,840,164 31,846
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 100,277,506 100.00 100,252,506 31,876

Company Background

Gufic BioSciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Gufic BioSciences Ltd
  • BSE Code : 2285.0
  • ISIN : INE742B01025

  • Incorporation Year

    1984

  • Registered Office

    Shop-37 1st Flr Kamala Bhavan
    Swami Nityanand Road Andheri(E, Mumbai,
    Maharashtra-400069

  • Telephone

    91-022-66919187/67261007/66919189

  • FAX

    91-022-26118103/26169008

  • Chairman

    Jayesh P Choksi

  • Managing Director

    Jayesh P Choksi

  • Company Secretary

    Ami Naresh Shah

  • Auditor

    Mittal Agarwal & Company

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    C-13 Pannalal Silk,
    Mills Cmpd LBS Marg,Bhandup West
    Mumbai - Mumbai - 400 078

Gufic BioSciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Gufic BioScience 384.20 808.84 806.67 55.12 16.52
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10